Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-04-29 Report Publication Anno…
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a Non-Deal Roadshow). It provides the date, location, purpose, and method of the meeting, and mentions that IR materials will be posted on the company's website and the Korea Exchange. Since the document is an announcement of an event and the availability of materials rather than the presentation itself, and it is under 5,000 characters, it falls under the Report Publication Announcement (RPA) category.
2025-04-29 Korean
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short notice titled '결산실적공시 예고' (Notice of Earnings Disclosure) from ST Pharm. It specifies the company name, the fiscal period (2025-01-01 to 2025-03-31), and the scheduled date for the actual earnings release (2025-04-29). Since this is an announcement regarding the timing of a future report publication rather than the report itself, it falls under the Report Publication Announcement (RPA) category.
2025-04-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (a conference call) scheduled for April 29, 2025. It provides logistical details such as time, location (online), and purpose (earnings call). Since it is an announcement of an event/presentation rather than the presentation slides themselves or a full report, and it fits the criteria for a regulatory announcement of an IR event, it is classified as a Regulatory Filing (RNS).
2025-04-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose (NDR participation), and the method of presentation. Since it is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a regulatory filing announcement regarding corporate events.
2025-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Annual General Meeting (AGM) for the company 'ST Pharm'. It details the outcomes of shareholder votes on financial statements, dividend declarations, director appointments, and other agenda items. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-03-31 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the specific terms of stock option grants to directors and employees, including exercise price, vesting periods, and valuation models. This type of disclosure is a standard regulatory requirement for listed companies in Korea regarding capital structure and equity-based compensation, fitting the 'Regulatory Filings' (RNS) category as it is a specific corporate disclosure filing that does not fall into the other specialized categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is for annual compensation reports).
2025-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.